Načítá se...
YAP and the Hippo pathway in cholangiocarcinoma
Cholangiocarcinoma (CCA) has an increasing incidence and remains a difficult to treat malignancy. In a search for more effective treatment options, progress has been made in identifying molecular drivers of oncogenic signaling including IDH mutations and FGFR2 fusions. In addition, multiple investig...
Uloženo v:
| Vydáno v: | J Gastroenterol |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Springer Japan
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6536462/ https://ncbi.nlm.nih.gov/pubmed/30815737 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00535-019-01563-z |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|